End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,130 KRW | -1.45% | -1.13% | +65.68% |
Business Summary
Number of employees: 174
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Devices, Pharmaceuticals, and Health Supplements Product
62.8
%
| - | - | 50,828 | 62.8 % | - |
Medical Devices, Pharmaceuticals, and Health Supplements Merchandise
36.8
%
| - | - | 29,806 | 36.8 % | - |
Other
0.4
%
| - | - | 363 | 0.4 % | - |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
51.3
%
| 32,583 | 77.0 % | 41,552 | 51.3 % | +27.53% |
Overseas Others
46.2
%
| 8,710 | 20.6 % | 37,437 | 46.2 % | +329.84% |
Russia
2.5
%
| 1,011 | 2.4 % | 2,008 | 2.5 % | +98.72% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Wan-Kyu Choi
CEO | Chief Executive Officer | 66 | 19/19/19 |
Sales & Marketing | 54 | - | |
Jae-Myeong Yang
AUD | Comptroller/Controller/Auditor | 73 | 11/19/11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Wan-Kyu Choi
CEO | Chief Executive Officer | 66 | 19/19/19 |
Man-Seok Jo
BRD | Director/Board Member | 59 | 11/19/11 |
Seong-Won Hong
BRD | Director/Board Member | 73 | 11/19/11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 67,912,443 | 52,966,894 ( 77.99 %) | 1,548,291 ( 2.280 %) | 77.99 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
BNC KOREA CO., LTD. 2.28% | 1,548,291 | 2.28% | 8,533,576 $ |
Company contact information
Sector
Sales per Business
Sales per region
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+65.68% | 300M | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-14.38% | 12.07B | |
-9.12% | 11.97B | |
-42.56% | 11.61B | |
+4.87% | 8.81B | |
-4.33% | 8.5B |
- Stock Market
- Equities
- A256840 Stock
- Company BNC Korea Co., Ltd.